Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary V Relling

Showing results (181-190 of 257) with videos related to

Pageof 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected]Deepa Bhojwani, Huining Kang, Renee X Menezes, et al.
Human Molecular Genetics|August 1, 2012
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicityGabriele Stocco, Wenjian Yang, Kristine R Crews, et al.
Pediatric Blood & Cancer|October 16, 2019
Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemiaEmily R Finch, Colton A Smith, Wenjian Yang, et al.
Leukemia|August 26, 2022
Epigenomic profiling of glucocorticoid responses identifies cis-regulatory disruptions impacting steroid resistance in childhood acute lymphoblastic leukemiaBrennan P Bergeron, Jonathan D Diedrich, Yang Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2019
Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16Sima Jeha, Deqing Pei, John Choi, et al.
JCO Precision Oncology|May 13, 2020
Factors Associated with Declining to Participate in a Pediatric Oncology Next Generation Sequencing StudyKatianne M Howard Sharp, Niki Jurbergs, Annastasia Ouma, et al.
Cancer Cell|June 28, 2002
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profilingEng-Juh Yeoh, Mary E Ross, Sheila A Shurtleff, et al.
Clinical Pharmacology and Therapeutics|March 26, 2021
Class II Human Leukocyte Antigen Variants Associate With Risk of Pegaspargase HypersensitivityYiwei Liu, Wenjian Yang, Colton A Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Childhood Acute Lymphoblastic Leukemia: Progress Through CollaborationChing-Hon Pui, Jun J Yang, Stephen P Hunger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2013
Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institute ALL Consortium Protocol 00-01Lynda M Vrooman, Kristen E Stevenson, Jeffrey G Supko, et al.
Pageof 26

Showing results (181-190 of 257) with videos related to

Sort By:
Pageof 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected]Deepa Bhojwani, Huining Kang, Renee X Menezes, et al.
Human Molecular Genetics|August 1, 2012
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicityGabriele Stocco, Wenjian Yang, Kristine R Crews, et al.
Pediatric Blood & Cancer|October 16, 2019
Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemiaEmily R Finch, Colton A Smith, Wenjian Yang, et al.
Leukemia|August 26, 2022
Epigenomic profiling of glucocorticoid responses identifies cis-regulatory disruptions impacting steroid resistance in childhood acute lymphoblastic leukemiaBrennan P Bergeron, Jonathan D Diedrich, Yang Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2019
Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16Sima Jeha, Deqing Pei, John Choi, et al.
JCO Precision Oncology|May 13, 2020
Factors Associated with Declining to Participate in a Pediatric Oncology Next Generation Sequencing StudyKatianne M Howard Sharp, Niki Jurbergs, Annastasia Ouma, et al.
Cancer Cell|June 28, 2002
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profilingEng-Juh Yeoh, Mary E Ross, Sheila A Shurtleff, et al.
Clinical Pharmacology and Therapeutics|March 26, 2021
Class II Human Leukocyte Antigen Variants Associate With Risk of Pegaspargase HypersensitivityYiwei Liu, Wenjian Yang, Colton A Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Childhood Acute Lymphoblastic Leukemia: Progress Through CollaborationChing-Hon Pui, Jun J Yang, Stephen P Hunger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2013
Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institute ALL Consortium Protocol 00-01Lynda M Vrooman, Kristen E Stevenson, Jeffrey G Supko, et al.
Pageof 26